PSYC Provides Update on Psychedelic Spotlight's Dynamic Q2 Year-over-Year Audience Growth of 708%
July 11 2022 - 8:30AM
InvestorsHub NewsWire
PSYC Provides Update
on Psychedelic Spotlight’s Dynamic Q2 Year-over-Year Audience
Growth of 708%
LAS VEGAS, NV -- July
11, 2022 -- InvestorsHub NewsWire -- PSYC
Corporation (OTCPink:
PSYC) (“PSYC” or the “Company”), a media leader focused on the
emerging psychedelic sector, announced that its flagship platform,
Psychedelic Spotlight, surpassed one million Page
Views in the month of June.
The accomplishment
comes after Psychedelic Spotlight surpassed one million Page Views
in the month of May. This is the first time the Company achieved
this milestone in consecutive months, and the development supports
the management team’s claim to make Psychedelic Spotlight the
top-ranking psychedelic news and information
platform.
Per the Company, other
notable statistics achieved within the month of June, as reported
through Google Analytics, were just under 1.2M total Impressions
and over 110,000 Organic Visits to the site, which, combined with
its ongoing top ranking on Google under the search category
“psychedelic news,” reinforces Psychedelic Spotlight’s emergence as
a recognized and respected leader for news, information, and unique
perspectives within the psychedelic
space.
Psychedelic
Spotlight’s second quarter (Q2) highlights of 2022, ending June 30,
are:
- Revenue:
$17K+
- Page Views:
2.95M
- Impressions:
3.58M
- Click Thru Rate (CTR):
5.53%
- Q2 over Q1 2022
Growth: Page Views 45% | Impressions 14.6% | CTR
30%
- Q2 2022 over Q2 2021
Growth: Page Views 708% | Impressions 264% | CTR
65.6%
“Psychedelic
Spotlight’s consistent monthly growth and overall performance
provides PSYC with a tremendous amount of inspiration and
encouragement, particularly as it relates to the fulfillment of our
long-standing objective of organically building a formidable leader
for news and media within this emerging sector of medicinal
psychedelics,” said PSYC CEO David Flores.
“We’ve all seen the beating the public markets absorbed throughout
the first half of 2022. However, the fact that the past two months
(May and June) are our strongest performing months yet is evidence
of Psychedelic Spotlight successfully emerging from these
challenges stronger than ever — just as the platform turns two
years old.”
“Going forward we plan on building revenue drivers not just from
the psychedelic sector itself, but also from ancillary sectors like
mental health & wellness, nutritional & dietary health,
physical health & athletic performance, nootropics, cannabis
& CBD, holistic lifestyle, and re-emerging practices from
ancient cultures, all of whom need to market to our rapidly
expanding audience.”
Psychedelic Spotlight
Marketing Director Maria Holyanova added, “We expect 2022 to be a
metamorphic year in which Psychedelic Spotlight continues to drive
substantial growth across our media and digital pipelines. I’m
incredibly proud of our team’s ability to deliver news regarding
advancements and regressions of the medicinal psychedelic space in
an honest, unbiased fashion. As research and development of novel
therapies to treat brain health disorders expands, Psychedelic
Spotlight will continue to solidify its position as the number one
news source in the psychedelic
sector.”
“Keeping the momentum
up from the previous quarter, Psychedelic Spotlight is quickly
growing beyond the 1M page views per month mark, which naturally
extended to an increase in downloads and views across our podcast,
social and video content,” said Psychedelic Spotlight Executive
Director Swati Sharma of the platform’s progress. “In addition,
we’ve managed to secure several top rankings for valuable
industry-related keywords through our editorial content,
catapulting us to the top of Google News on a consistent basis.
Being listed beside media giants such as Forbes, Business Insider,
CNN, BBC, GlobalNewsWire, Scientific American, and others is a true
indicator of the success we’ll continue to achieve within the
psychedelic sector.”
“Psychedelic
Spotlight’s growth trends undeniably confirm our team's ability to
build, maintain, and grow an organic audience from scratch,”
concluded PSYC CFO Craig Schlesinger. “Money began flowing back
into the public markets during the second half of Q2, as did demand
for Psychedelic Spotlight. Based on last month’s report
by Data Bridge Market
Research, the U.S. psychedelic
drug market alone can reach an estimated $9.8B by 2029 from a
robust compounded annual growth rate (CAGR) of 16.8%. Psychedelic
Spotlight’s audience growth is currently trending well above that
benchmark, and we expect dynamic monetization and revenue growth
for the industry’s leading news and multimedia platform to follow.
It’s an exciting time for Team
PSYC.”
About PSYC
Corporation (OTCPink:
PSYC)
At PSYC
Corporation we are integrating media, creativity, and technology to
develop and deploy thought-provoking ideas and solutions that are
fostering and transforming the approach to some of society’s most
pressing matters.
PSYC has
expressed its intent and commitment to positioning itself at the
forefront of the psychedelic revolution and as a resource center
for discovering and understanding the latest research and business
opportunities surrounding psychedelic inspired medicines. In
conjunction with the FDA’s more open-minded approach to psychedelic
medicines, and as several major U.S. cities continue to approve the
decriminalization of psilocybin, we believe investors are
speculating that the psychedelic boom could be bigger than that of
cannabis. PSYC is your source for current investment related news
specific to psychedelic medicines and cutting-edge research
improving overall health, moving this sector into the
mainstream.
We are
dedicated to a forward-thinking approach that embraces
groundbreaking new technology and innovations and through the
vision of business development we intend to continue to evolve into
these unchartered territories as the industry leaders of the
future.
Forward-Looking Statements Disclaimer:
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. In some
cases, you can identify forward-looking statements by the following
words: "anticipate," "believe," "continue," "could," "estimate,"
"expect," "intend," "may," "ongoing," "plan," "potential,"
"predict," "project," "should," "will," "would," or the negative of
these terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, the
adverse effect of the Omicron variant, that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com website and is not
incorporated by reference into such
reports.
Disclaimer: PSYC Corporation does not in any way encourage or
condone the use, purchase, sale or transfer of any illegal
substances, nor do we encourage or condone partaking in any
unlawful activities. We support a harm reduction approach for the
purpose of education and promoting individual and public safety. If
you are choosing to use psychedelic substances, please do so
responsibly.
Corporate
Contact:
PSYC
Corporation (PSYC)
www.psyccorporation.com
(702)
761-6716
info@psyccorporation.com
OTCPINK: PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Jul 2024 to Aug 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Aug 2023 to Aug 2024